MedTrace Logo

Fluoxetine for Motor Recovery After Acute Intracerebral Hemorrhage

NCT01737541 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2014-08-22

No results posted yet for this study

Summary

This is a randomized, double-blind, placebo-controlled, multicenter clinical trial that will be carried out in Mexico. The purpose of this study is to test whether a 3-month treatment with fluoxetine enhances motor recovery in non-depressed patients with acute intracerebral hemorrhage.

Conditions

  • Intracerebral Hemorrhage
  • Motor Impairment

Interventions

DRUG

Fluoxetine

DRUG

Placebo

Sponsors & Collaborators

  • Universidad Autónoma de Aguascalientes

    lead OTHER

Principal Investigators

  • Juan M Marquez-Romero, MD · Universidad Autónoma de Aguascalientes

  • Angel A Arauz, PhD · Instituto Nacional de Neurología y Neurocirugía

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2014-08-31
Completion
2014-08-31

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01737541 on ClinicalTrials.gov